// App-Quantinova.ai

24 : Long-Term Safety and Efficacy of Certolizumab Pegol in Combination with Methotrexate in the Treatment of Rheumatoid Arthritis: 5-Year Results from a 52-Week Randomized Controlled Trial and Open-Label Extension Study

Researchers

Presenter

  • Robert Landewe

Principal Investigators

  • Ronald Van Vollenhoven

  • Bernard Combe

  • Vibeke Strand

  • Phillip Mease

  • Laura Shaughnessy

  • Brenda Van Lunen

  • Desiree Van der Heijde

  • Barb Phenix

Medical Centers

  • Mount Sinai Hospital, Toronto, ON, Canada

  • Hopital Lapeyronie, 34295 Montpellier,France

  • Leiden University Medical Centre, Leiden, Netherlands

Locations

  • France

  • Canada

  • Netherlands

Companies

  • N/A

Study Components

Therapeutic Area

  • Autoimmune (AI)

Disease

  • Rheumatoid arthritis

Biomarkers

  • Estrogen receptor alpha

Drug/Treatment

  • Certolizumab pegol

  • Methotrexate

Outcome

  • Unknown

Study Design

  • randomized

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Interim

Copyright © 2026. QuantiNova All rights reserved